Back to calendar
Cartesian Therapeutics, Inc. (RNAC) Earnings
RNAC reports earnings on Thursday, November 5, 2026
earnings report
November 5, 2026 · Before Market Open
Q3 2026
Est. EPS: $-1.01
Actual EPS: $0.46
EPS surprise: 152.40%
Company overview
Market Cap$290.5M
PriceUSD 9.60
EPS (TTM)-5.94
52-week high11.00
52-week low5.60
SectorHealth Technology
IndustryBiotechnology
Employees75